Again Breaking News from NIH for biomedical research
The U.S. The National Institutes of Health (NIH) has announced an investment of more than $150 million to advance human‑…
New Video: Advancing Engine Emissions Research at SR Technicss
Following the successful installation of the VITROCELL AirTox Monitor at the SR Technics Group test facilities, we’re ex…
Why suspend a powder if you don’t have to?
Dry Powder Exposure Systems enable the direct aerosolization of dry powders — without first transferring them into suspe…
Why comparability matters in dosimetry
Results of inline photometer can only be interpreted with confidence when data is aligned across systems, setups, and ov…
What makes VITROCELL unique?
It is not one single feature, one product, or one technical specification. It is the combination of things that matter…
Know your dose. Improve your data.
All in a single, controlled run: fewer moving parts, cleaner curves. Why it helps your stats • Parallel replicates in…
How do you get NAMs-ready, human relevant data on anesthetic safety?
The debate on anesthetic effects in the developing brain has been stuck on mixed and often non-human data. FDA/NCTR used…
New Research Highlight: Validating the VITROCELL Cloud Alpha MOVE
We’re proud to see our technology featured in the latest poster by Matthew Sheavyn & Victoria Pack from Dstl. Dstl is o…
Organ-on-Chip (OoC) Exposure – From Gas to Dry Powders in One Complete Solution
Vitrocell and AlveoliX set the benchmark in Organ-on-chip technology, delivering complete aerosol capability on chip for…
Meet Navetta: New Approach to Safety Testing of Drugs and Particles
Navetta offers an innovative solution for safety testing of drugs and particles at the Air-Liquid Interface. What makes…
